课题基金 / 基金详情

Pathogenesis of COVID-19 mediated Cardiovascular Complications: Therapeutic Applications

Pathogenesis of COVID-19 mediated Cardiovascular Complications: Therapeutic Applications
COVID-19 介导的心血管并发症的发病机制:治疗应用
批准号:
433317
负责人:
Oudit Gavin Y
金额:
$63.81万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2020
资助国家:
加拿大
项目状态:
未结题
起止时间:
2020-10-01 至 2025-10-01

项目摘要

项目成果

Oudit Gavin Y的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
COVID-19, caused by SARS-CoV-2 has caused a worldwide pandemic. Male patients have a worse outcome compared to the females. COVID-19 infection leads to SARS but the cardiovascular (CV) system is also highly involved. This is because the molecule that medi
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Angiotensin Converting Enzyme 2 in Cardiovascular Complications due to Metabolic Disorders
  • 批准号:
    444982
  • 项目类别:
    Operating Grants
  • 资助金额:
    $60.75万
  • 财政年份:
    2021
  • 负责人:
    Oudit Gavin Y
  • 依托单位:
Novel Interplay between the Apelin Pathway and Neutral Endopeptidase in Heart Disease
  • 批准号:
    407964
  • 项目类别:
    Operating Grants
  • 资助金额:
    $55.45万
  • 财政年份:
    2019
  • 负责人:
    Oudit Gavin Y
  • 依托单位:
Canada Research Chair Tier 2
  • 批准号:
    392605
  • 项目类别:
  • 资助金额:
    $36.43万
  • 财政年份:
    2018
  • 负责人:
    Oudit Gavin Y
  • 依托单位:
Role of PI3Kinase alpha in Cardiovascular Disease and Cardiotoxicity
  • 批准号:
    369565
  • 项目类别:
    Operating Grants
  • 资助金额:
    $51.27万
  • 财政年份:
    2017
  • 负责人:
    Oudit Gavin Y
  • 依托单位: